Skip to main content
. 2021 Sep 28;12(20):2075–2088. doi: 10.18632/oncotarget.28060

Table 3. Freedom from progression after radioembolization for intrahepatic cholangiocarcinoma in 28 patients.

Freedom from Progression %
6 months 12 months 18 months 24 months 30 months
Location of tumor progression
In-field 96 89 89 67 67
Out-of-field 77 51 51 51 51
Overall 77 51 51 40 40